BiotechTube

Oxymetazoline HCL 1.0% Cream

ApprovedCompleted
0 views this week 0 watching💤 Quiet
Interest: 33/100
33
Hype Score

Development Stage

✓
Pre-clinical
✓
Phase 1
✓
Phase 2
✓
Phase 3
5
Approved
Indication / Disease

Rosacea

Conditions

Rosacea

Trial Timeline

Dec 4, 2017 → Jun 15, 2018

NCT ID
NCT03380390

About Oxymetazoline HCL 1.0% Cream

Oxymetazoline HCL 1.0% Cream is a approved stage product being developed by Aclaris Therapeutics for Rosacea. The current trial status is completed. This product is registered under clinical trial identifier NCT03380390. Target conditions include Rosacea.

What happened to similar drugs?

4 of 14 similar drugs in Rosacea were approved

Approved (4) Terminated (2) Active (8)
🔄DFD-29 + Doxycycline + PlaceboDr. Reddy's LaboratoriesPhase 3
🔄DFD-29 + Doxycycline + PlaceboDr. Reddy's LaboratoriesPhase 3
✅Azelaic acid (Finacea, BAY39-6251) + Metronidazole (Metrogel) + Doxycycline (Oracea)BayerApproved
✅Azelaic acid 15% + Brimonidine 0.33%BayerApproved
✅Azelaic Acid foam 15%BayerApproved
✅azelaic acid 15% gel + azelaic acid 15% gelBayerApproved
🔄Azelaic acid foam, 15% (BAY39-6251) + Vehicle foamBayerPhase 3

Hype Score Breakdown

Clinical
20
Activity
8
Company
5
Novelty
0
Community
0

Clinical Trials (1)

NCT IDPhaseStatus
NCT03380390ApprovedCompleted

Competing Products

20 competing products in Rosacea

See all competitors
ProductCompanyStageHype Score
DFD-04 OintmentDr. Reddy's LaboratoriesPhase 2
32
Minocycline hydrochloride capsulesDr. Reddy's LaboratoriesPhase 1
26
DFD-29 + Doxycycline + PlaceboDr. Reddy's LaboratoriesPhase 3
37
DFD-29 Extended Release Capsules (40 mg) + DFD-29 Extended Release Capsules (20 mg) + Oraycea® (doxycycline) Capsules + Placebo CapsulesDr. Reddy's LaboratoriesPhase 2
32
DoxycyclineDr. Reddy's LaboratoriesPhase 1
26
DFD-29 + Doxycycline + PlaceboDr. Reddy's LaboratoriesPhase 3
37
Lotilaner Gel, 2.0%Tarsus PharmaceuticalsPhase 2
29
lotilaner + VehicleTarsus PharmaceuticalsPhase 2
36
DRM02Eli LillyPhase 2
35
Clascoterone Cream 1%Sun PharmaceuticalPhase 2
42
Metronidazole Topical Gel 1% + Metronidazole Topical Gel 1% (Metrogel) + PlaceboSun PharmaceuticalPhase 1
29
Azelaic Acid 15% topical gel + Finacea® (azelaic acid) Gel, 15% + PlaceboSun PharmaceuticalPhase 1
29
Azelaic acid foam 15% + Finacea® (Azelaic acid Foam) 15% + Vehicle of the test productSun PharmaceuticalPhase 1
29
Laropiprant + Placebo for LaropiprantMerckPhase 1
29
AMG 334NovartisPhase 2
31
BFH772 1% ointment + Vehicle ointment + Noritate® 1% creamNovartisPhase 2
35
Deucravacitinib + PlaceboBristol Myers SquibbPhase 2
27
Azelaic acid (Finacea, BAY39-6251) + Metronidazole (Metrogel) + Doxycycline (Oracea)BayerApproved
40
Coppertone, BAY1183345BayerPre-clinical
23
Azelaic acid 15% + Brimonidine 0.33%BayerApproved
40